- Home
- XELB vs GLMD Comparison
XELB vs GLMD Comparison
Compare XELB & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XELB
- GLMD
- Stock Information
- Founded
- XELB 2011
- GLMD 2000
- Country
- XELB United States
- GLMD Israel
- Employees
- XELB N/A
- GLMD N/A
- Industry
- XELB Multi-Sector Companies
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- XELB Miscellaneous
- GLMD Health Care
- Exchange
- XELB Nasdaq
- GLMD Nasdaq
- Market Cap
- XELB 3.7M
- GLMD 4.1M
- IPO Year
- XELB N/A
- GLMD 2014
- Fundamental
- Price
- XELB $1.10
- GLMD $1.55
- Analyst Decision
- XELB
- GLMD Hold
- Analyst Count
- XELB 0
- GLMD 1
- Target Price
- XELB N/A
- GLMD N/A
- AVG Volume (30 Days)
- XELB 307.5K
- GLMD 396.4K
- Earning Date
- XELB 08-13-2025
- GLMD 08-27-2025
- Dividend Yield
- XELB N/A
- GLMD N/A
- EPS Growth
- XELB N/A
- GLMD N/A
- EPS
- XELB N/A
- GLMD N/A
- Revenue
- XELB $7,407,000.00
- GLMD N/A
- Revenue This Year
- XELB $23.96
- GLMD N/A
- Revenue Next Year
- XELB $53.02
- GLMD N/A
- P/E Ratio
- XELB N/A
- GLMD N/A
- Revenue Growth
- XELB N/A
- GLMD N/A
- 52 Week Low
- XELB $1.02
- GLMD $1.15
- 52 Week High
- XELB $8.49
- GLMD $23.80
- Technical
- Relative Strength Index (RSI)
- XELB 20.32
- GLMD 38.58
- Support Level
- XELB $1.50
- GLMD $1.79
- Resistance Level
- XELB $1.69
- GLMD $2.09
- Average True Range (ATR)
- XELB 0.13
- GLMD 0.20
- MACD
- XELB -0.02
- GLMD -0.06
- Stochastic Oscillator
- XELB 9.74
- GLMD 7.06
About XELB Xcel Brands Inc.
Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.